Mission BioCapital Denmark ApS
CVR 45390241 · Private limited company (ApS) · Active · Medium risk
Mission BioCapital Denmark ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry virksomhedsrådgivning og anden ledelsesrådgivning. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK -2.0m and a net result of DKK -2.0m. CEO: Johannes Heinrich Frühauf, Peter Daniel Parker, Douglas Kingsley Crawford, Steven Webb Tregay.
Bankruptcy risk for Mission BioCapital Denmark ApS
1.0 × the average (1.41%) · higher risk than 77% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45390241
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (1 years)
- Address
- Ole Maaløes Vej 3
2200 København N - Municipality
- København
- Industry
- Virksomhedsrådgivning og anden ledelsesrådgivning (702000)
Bankruptcies in the industry: Virksomhedsrådgivning og anden rådgivning om driftsledelse - Share capital
- DKK 40k
- Auditor
- KPMG
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 1 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 167 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 |
|---|---|
| Gross profit | DKK -829k |
| Net profit | DKK -2.0m |
| Equity | DKK -2.0m |
| Total assets | DKK 0 |
| Short-term debt | DKK 2.0m |
| Avg. employees | 1 |
Latest annual report: Reporting class B · auditor's statement: Auditor's reports (Other non-assurance reports) · KPMG.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 10 Feb 2025 – 31 Dec 2025 | 181 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Johannes Heinrich Frühauf | Current | |
| CEO | Peter Daniel Parker | Current | |
| CEO | Douglas Kingsley Crawford | Current | |
| CEO | Steven Webb Tregay | Current | |
| Owner (100%) | Mission BioCapital Management Company LLC | Current | |
| Founder | Mission BioCapital Management Company LLC | Current |
Address history (0 moves)
| Ole Maaløes Vej 3, 2200 København N |
Other companies at the same address
- 25-06-2019 ApS Bankrupt
- Ankrin Therapeutics ApS Bankrupt
- Avineuro ApS Bankrupt
- BIOREPELLER IVS Bankrupt
- Bainan Biotech ApS Bankrupt
- Broselid Holding IVS Bankrupt
- ChildTreat ApS Bankrupt
- Dencomm ApS Bankrupt
- IO BIOTECH ApS Bankrupt
- Invitreo Biosciences ApS Bankrupt
- Lab Hos Development ApS Bankrupt
- MGM BIO IVS Bankrupt
- Mind the Byte ApS Bankrupt
- PanCryos ApS Bankrupt
- Ressaissi Holding IVS Bankrupt
- SSIP 2023 ApS Bankrupt
- Spit Test Company ApS Bankrupt
- Sterisafe Holding A/S Bankrupt
- Sumondo ApS Bankrupt
- TychoBio IVS Bankrupt
- aiwell Nordic ApS Bankrupt
- 1stBiome ApS Active
- 3Sonic ApS Active
- 55 North General Partner I ApS Active
- 55 North Management ApS Active
Similar companies in København
- PROXIMA INTERNATIONAL ApS København Ø
- TALODOM ApS København K
- KASI HOLDING ApS København K
- MOGENSEN A/S København S
- COBO Consult ApS København N
- PA CONSULTING GROUP A/S Nordhavn
- A.T. KEARNEY DENMARK A/S København K
- J&P Invest, Kbh. ApS København K
- RAMBØLL MANAGEMENT CONSULTING A/S København S
- SELSKABET AF DEN 19.10.2026 A/S København Ø
- Asante Management ApS København SV
- Digital Transformation Capital Partners Denmark ApS København Ø
Questions and answers about Mission BioCapital Denmark ApS
Has Mission BioCapital Denmark ApS gone bankrupt?
No, Mission BioCapital Denmark ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Mission BioCapital Denmark ApS?
Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.
Who is the CEO of Mission BioCapital Denmark ApS?
Johannes Heinrich Frühauf, Peter Daniel Parker, Douglas Kingsley Crawford, Steven Webb Tregay are the CEOs of Mission BioCapital Denmark ApS.
Who is the auditor of Mission BioCapital Denmark ApS?
Mission BioCapital Denmark ApS most recently used KPMG.
When was Mission BioCapital Denmark ApS founded?
Mission BioCapital Denmark ApS was founded on 10 February 2025.
What is the equity of Mission BioCapital Denmark ApS?
Equity was DKK -2.0m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.